149 related articles for article (PubMed ID: 17037976)
1. The multiple endocrine neoplasia syndromes.
Lakhani VT; You YN; Wells SA
Annu Rev Med; 2007; 58():253-65. PubMed ID: 17037976
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
3. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia, the old and the new: a mini review.
Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
6. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic.
Jindrichová S; Vcelák J; Vlcek P; Neradilová M; Nemec J; Bendlová B
J Endocrinol; 2004 Nov; 183(2):257-65. PubMed ID: 15531714
[TBL] [Abstract][Full Text] [Related]
7. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.
Marsh DJ; Robinson BG; Andrew S; Richardson AL; Pojer R; Schnitzler M; Mulligan LM; Hyland VJ
Genomics; 1994 Sep; 23(2):477-9. PubMed ID: 7835899
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of multiple endocrine neoplasia].
Conte-Devolx B; Niccoli P;
Bull Acad Natl Med; 2010 Jan; 194(1):69-78; discussion 78-9. PubMed ID: 20669560
[TBL] [Abstract][Full Text] [Related]
10. Targeting the RET pathway in thyroid cancer.
Wells SA; Santoro M
Clin Cancer Res; 2009 Dec; 15(23):7119-23. PubMed ID: 19934298
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and surgical treatment of multiple endocrine neoplasia.
Zhou GW; Wei Y; Chen X; Jiang XH; Li XY; Ning G; Li HW
Chin Med J (Engl); 2009 Jul; 122(13):1495-500. PubMed ID: 19719936
[TBL] [Abstract][Full Text] [Related]
12. [Multiple endocrine neoplasia].
Schaaf L; Raue F
Dtsch Med Wochenschr; 2017 Sep; 142(18):1379-1389. PubMed ID: 28902384
[TBL] [Abstract][Full Text] [Related]
13. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
Kameyama K; Okinaga H; Takami H
Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
[TBL] [Abstract][Full Text] [Related]
14. [Multiple endocrine neoplasia: genetic aspects].
Calender A;
Bull Acad Natl Med; 2010 Jan; 194(1):81-95; discussion 95-6. PubMed ID: 20669561
[TBL] [Abstract][Full Text] [Related]
15. Animal models of multiple endocrine neoplasia.
Wiedemann T; Pellegata NS
Mol Cell Endocrinol; 2016 Feb; 421():49-59. PubMed ID: 26184857
[TBL] [Abstract][Full Text] [Related]
16. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
[TBL] [Abstract][Full Text] [Related]
17. [Neural crest and multiple endocrinopathies].
Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M
C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721
[TBL] [Abstract][Full Text] [Related]
18. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
Frank-Raue K; Rondot S; Schulze E; Raue F
Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401
[TBL] [Abstract][Full Text] [Related]
19. Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes.
Wells SA; Donis-Keller H
Endocrinol Metab Clin North Am; 1994 Mar; 23(1):215-28. PubMed ID: 7913027
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]